TSN - Tyson Foods, Inc.
NYSE
->
Consumer Defensive
->
Farm Products
Springdale,
United States
Type: Equity
TSN price evolution
TSN
| (in millions $) | 28 Oct 2024 | 29 Jul 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2569 | $2182 | $1484 | |
| Short term investments | ||||
| Net receivables | $2406 | $2389 | $2358 | $2263 |
| Inventory | $5195 | $5033 | $5056 | $5087 |
| Total current assets | $9751 | $10572 | $9966 | $9216 |
| Long term investments | ||||
| Property, plant & equipment | $10152 | $9368 | $9593 | $9672 |
| Goodwill & intangible assets | $15729 | $15863 | $15931 | |
| Total noncurrent assets | $27160 | $27499 | $27530 | |
| Total investments | ||||
| Total assets | $37100 | $37732 | $37465 | $36746 |
| Current liabilities | ||||
| Accounts payable | $2402 | $2291 | $2244 | $2623 |
| Deferred revenue | ||||
| Short long term debt | $1320 | $1315 | $1308 | |
| Total current liabilities | $4787 | $5810 | $5633 | $6172 |
| Long term debt | $9713 | $9701 | $9645 | $8370 |
| Total noncurrent liabilities | $13720 | $13609 | $12286 | |
| Total debt | $11021 | $10960 | $9678 | |
| Total liabilities | $18710 | $19656 | $19376 | $18458 |
| Shareholders' equity | ||||
| Retained earnings | $18873 | $18687 | $18667 | $18693 |
| Other shareholder equity | -$184 | -$295 | -$252 | -$205 |
| Total shareholder equity | $18076 | $18089 | $18150 | |
| (in millions $) | 28 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $573 | $1031 | $2507 | |
| Short term investments | ||||
| Net receivables | $2406 | $2476 | $2577 | $2400 |
| Inventory | $5195 | $5328 | $5514 | $4382 |
| Total current assets | $9751 | $8722 | $9630 | $9822 |
| Long term investments | ||||
| Property, plant & equipment | $10152 | $9634 | $8685 | $7837 |
| Goodwill & intangible assets | $15976 | $16765 | $17068 | |
| Total noncurrent assets | $27529 | $27191 | $26487 | |
| Total investments | ||||
| Total assets | $37100 | $36251 | $36821 | $36309 |
| Current liabilities | ||||
| Accounts payable | $2402 | $2594 | $2483 | $2225 |
| Deferred revenue | ||||
| Short long term debt | $1895 | $459 | $1067 | |
| Total current liabilities | $4787 | $6499 | $5313 | $6325 |
| Long term debt | $9713 | $7611 | $7862 | $8281 |
| Total noncurrent liabilities | $11497 | $11697 | $12130 | |
| Total debt | $9506 | $8321 | $9348 | |
| Total liabilities | $18710 | $17996 | $17010 | $18455 |
| Shareholders' equity | ||||
| Retained earnings | $18873 | $18760 | $20084 | $17502 |
| Other shareholder equity | -$185 | -$260 | -$297 | -$172 |
| Total shareholder equity | $18133 | $19702 | $17723 | |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13565 | $13353 | $13319 | |
| Cost of revenue | $12475 | $12496 | ||
| Gross Profit | $1081 | $878 | $823 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $537 | $592 | ||
| Total operating expenses | $535 | $537 | $592 | |
| Operating income | $341 | $231 | ||
| Income from continuing operations | ||||
| EBIT | $383 | $259 | ||
| Income tax expense | $111 | $57 | $47 | |
| Interest expense | -$64 | $135 | $105 | |
| Net income | ||||
| Net income | $357 | $191 | $107 | |
| Income (for common shares) | $191 | $107 | ||
| (in millions $) | 28 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $53309 | $52881 | $53282 | $47049 |
| Cost of revenue | $50250 | $46614 | $40523 | |
| Gross Profit | $3905 | $2631 | $6668 | $6526 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2245 | $2258 | $2130 | |
| Total operating expenses | $2187 | $3026 | $2258 | $2130 |
| Operating income | -$395 | $4410 | $4396 | |
| Income from continuing operations | ||||
| EBIT | -$322 | $4503 | $4456 | |
| Income tax expense | $270 | -$29 | $900 | $981 |
| Interest expense | -$351 | $355 | $365 | $428 |
| Net income | ||||
| Net income | $800 | -$648 | $3238 | $3047 |
| Income (for common shares) | -$648 | $3238 | $3047 | |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $191 | $145 | $107 | |
| Operating activities | ||||
| Depreciation | $360 | $349 | $373 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $796 | -$123 | $1300 | |
| Investing activities | ||||
| Capital expenditures | -$263 | -$267 | -$354 | |
| Investments | -$3 | -$27 | ||
| Total cash flows from investing | -$888 | -$233 | -$243 | -$378 |
| Financing activities | ||||
| Dividends paid | -$684 | -$171 | -$171 | -$171 |
| Sale and purchase of stock | -$12 | -$17 | -$6 | |
| Net borrowings | $25 | $1280 | $148 | |
| Total cash flows from financing | -$581 | -$168 | $1077 | -$26 |
| Effect of exchange rate | $23 | -$8 | -$13 | $15 |
| Change in cash and equivalents | $1144 | $387 | $698 | $911 |
| (in millions $) | 28 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$648 | $3238 | $3047 | |
| Operating activities | ||||
| Depreciation | $1339 | $1202 | $1214 | |
| Business acquisitions & disposals | -$262 | $1188 | ||
| Stock-based compensation | $61 | $93 | $91 | |
| Total cash flows from operations | $1752 | $2687 | $3840 | |
| Investing activities | ||||
| Capital expenditures | -$1939 | -$1887 | -$1209 | |
| Investments | -$117 | -$178 | -$46 | |
| Total cash flows from investing | -$888 | -$2299 | -$1935 | $58 |
| Financing activities | ||||
| Dividends paid | -$684 | -$670 | -$653 | -$636 |
| Sale and purchase of stock | -$343 | -$576 | -$26 | |
| Net borrowings | $1117 | -$1088 | -$2047 | |
| Total cash flows from financing | -$581 | $88 | -$2323 | -$2731 |
| Effect of exchange rate | $23 | $1 | -$35 | $4 |
| Change in cash and equivalents | $1144 | -$458 | -$1606 | $1171 |
News
Fundamentals
| Market cap | $18.29B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 356.00M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 1.63% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.04 |
| Quick ratio | 0.95 |